References
- Schwartz R. H., Hawks R. L. Laboratory detection of marijuana use. JAMA 1985; 254(6)788–792
- Hawks R. L., Chiang C. N. Examples of specific drug assays, Marijuana/Cannabinoids. Urine Testing for Drugs of Abuse, National Institute on Drug Abuse Research Monograph Series 1986; 73: 84–92
- McBurney L. J., Bobbie B. A., Sepp L. A. GC/MS and EMIT analyses for delta-9-tetrahydrocannabinol metabolites in plasma and urine of human subjects. J. Anal. Toxicol. 1986; 10: 56–64
- Irving J., Leeb B., Foltz R. L., Cook C. E., Bursey J. T., Willette R. E. Evaluation of immunoassays for cannabinoids in urine. J. Anal. Toxicol. 1984; 8: 192–196
- Taylor E. H., Pappas A. A. Computerized interpretation of gas chromatography mass spectrometry (GC/MS) results for confirmation of drugs. Manual of Procedures for the Seminar on Analytical Toxicology, F. W. Sunderman. Institute for Clinical Science Inc., Philadelphia 1987; 19–29
- Nahas G. G. Cannabis: Toxicological properties and epidemiological aspects. Med. J. Austr. 1986; 145: 82–87
- Little P. J., Kaplan N. C., Martin B. R. Pharmacological profile of delta-9-THC caramate. Alc. Drug Res. 1987; 7: 517–523
- Wall M. E., Perez-Reyes M. The metabolism of delta-9-tetrahydrocannabinol and related cannabinoids in man. J. Clin. Pharmacol. 1981; 21: 1785–1895
- Vollner L., Bieniek D., Forte K. Review of analytical methods for identification and quantification of cannabis products. Reg. Toxicol and Pharmacol. 1986; 6: 348–358
- Dakis C. A., Pottash A. L.C., Annitte W., Gold M. Persistence of urinary marijuana levels after supervised abstinence. Am. J. Psychiatry 1982; 139: 1196–1198
- Manno J. E. Interpretation of urinalysis results. Urine Testing for Drugs of Abuse, R. L. Hawks, C. N. Chiang. Monograph Series, National Institute on Drug Abuse Research. 1986; 73: 54–61